News
Roche's Parkinson's hope fails second clinical trial
An experimental therapy for Parkinson's disease being developed by …
20123 items found
News
Novo completes $16.5bn takeover of Catalent
Novo Holdings' $16.5 billion acquisition of US contract development …
News
Ottimo raises $140m for its PD-1/VEGF cancer drug
Anglo-US biotech Ottimo Pharma has completed a big early-stage …
R&D
How small molecule-focused CDMOs can navigate the impact of the Inflation Reduction Act
As large-molecule drugs and weight-loss therapeutics dominate …
News
MSD makes its obesity move with $2bn Hansoh deal
MSD has been rumoured to be considering a takeover of Viking …
News
Mesoblast finally pushes GvHD cell therapy over finish line
At its third attempt, Mesoblast has secured FDA approval for Ryoncil …
R&D
Sponsored
Innovative sublingual medication for improved stroke care
Stroke poses a major threat to public health, and this threat is …
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with …
Patients
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
People with obesity in Western cultures have largely been subject to …
News
Novo Holdings leads $100m round for novel painkiller biotech
SiteOne Therapeutics has completed a $100 million third-round …
News
Sensorion encouraged by deafness gene therapy data
Sensorion's gene therapy for otoferlin-related hearing loss – a …
News
Lilly's Alzheimer's drug Kisunla is cleared in China
Eli Lilly has chalked up another regulatory approval for its …
Market Access
Life Sciences Industry Report 2025 PART 1
In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
